Beta Bionics, Inc.(BBNX)
Health Care Equipment
Cardiovascular Devices
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | Hopman Mark Chief Commercial Officer | Sale | -275 | -0.21%130,612 | $12.31 | $3,385 | View SEC filing | |
| 2026-06-05 | Jones Christy Director | Sale | -2,811 | -9.30%27,400 | $14.00 | $39,354 | View SEC filing | |
| 2026-06-03 | Russell Steven Jon Chief Medical Officer | Sale | -4,222 | -2.37%173,849 | $12.61 | $53,227 | View SEC filing | |
| 2026-06-03 | Saint Sean President & CEO | Sale | -16,872 | -3.85%420,937 | $12.61 | $212,707 | View SEC filing | |
| 2026-06-03 | Feider Stephen Chief Financial Officer | Sale | -6,676 | -3.87%166,053 | $12.61 | $84,165 | View SEC filing | |
| 2026-06-03 | Mensinger Mike Chief Product Officer | Sale | -4,378 | -2.32%184,415 | $12.61 | $55,194 | View SEC filing | |
| 2026-06-03 | Hopman Mark Chief Commercial Officer | Sale | -5,329 | -3.91%130,887 | $12.61 | $67,183 | View SEC filing | |
| 2026-05-26 | Jones Christy Director | Sale | -1,998 | -13.11%13,246 | $9.95 | $19,880 | View SEC filing | |
| 2026-05-26 | Lezack Adam Director | Sale | -1,998 | -4.89%38,831 | $10.58 | $21,138 | View SEC filing | |
| 2026-03-16 | Russell Steven Jon Chief Medical Officer | Sale | -1,025 | -0.57%178,071 | $29.34 | $30,069 | View SEC filing | |
| 2026-03-16 | Hopman Mark Chief Commercial Officer | Sale | -2,917 | -2.10%136,216 | $30.27 | $88,304 | View SEC filing | |
| 2026-03-05 | Hopman Mark Chief Commercial Officer | Sale | -353 | -0.25%139,133 | $11.57 | $4,084 | View SEC filing | |
| 2026-03-03 | Russell Steven Jon Chief Medical Officer | Sale | -1,026 | -0.57%179,096 | $12.36 | $12,683 | View SEC filing | |
| 2026-03-03 | Saint Sean President & CEO | Sale | -3,384 | -0.77%437,809 | $12.36 | $41,832 | View SEC filing | |
| 2026-03-03 | Feider Stephen Chief Financial Officer | Sale | -1,428 | -0.82%172,729 | $12.36 | $17,652 | View SEC filing | |
| 2026-03-03 | Mensinger Mike Chief Product Officer | Sale | -1,064 | -0.56%188,793 | $12.36 | $13,153 | View SEC filing | |
| 2026-03-03 | Hopman Mark Chief Commercial Officer | Sale | -834 | -0.59%139,486 | $12.36 | $10,310 | View SEC filing | |
| 2026-01-07 | Mensinger Mike Chief Product Officer | Sale | -2,200 | -2.65%80,752 | $30.10 | $66,221 | View SEC filing | |
| 2026-01-05 | Feider Stephen Chief Financial Officer | Sale | -20,000 | -31.94%42,614 | $29.53 | $590,680 | View SEC filing | |
| 2026-01-05 | Mensinger Mike Chief Product Officer | Sale | -7,800 | -8.59%82,952 | $29.61 | $230,950 | View SEC filing | |
| 2025-12-04 | Saint Sean President & CEO | Sale | -3,278 | -3.24%97,924 | $29.34 | $96,163 | View SEC filing | |
| 2025-12-04 | Feider Stephen Chief Financial Officer | Sale | -1,427 | -3.24%42,614 | $29.34 | $41,862 | View SEC filing | |
| 2025-12-04 | Mensinger Mike Chief Product Officer | Sale | -1,063 | -1.16%90,752 | $29.34 | $31,184 | View SEC filing | |
| 2025-12-02 | Lezack Adam Director | Sale | -1,406 | -14.29%8,435 | $29.55 | $41,543 | View SEC filing | |
| 2025-12-02 | Palasis Maria Director | Sale | -1,406 | -14.29%8,435 | $29.55 | $41,552 | View SEC filing |
1-25 of 47